[Pe-055] English Poster Session 055「Neurogenetics, Gene therapy, and iPS cell 3」

[Pe-055-5] Establishment of an epilepsy iPSC cohort for disease modeling and drug discovery

Mika Suga^1,2, Takayuki Kondo^1,2,3, Keiko Imamura^1,2,3, Ran Shibukawa¹, Yukako Sagara¹, Yaya Taketsuna¹, Takako Enami^2,3, Ayako Nagahashi^2,3, Masako Kinoshita⁴, Toshiyuki Yamamoto⁵, Yushi Inoue⁶, Katsuya Kobayashi⁷, Takefumi Hitomi⁸, Riki Matsumoto⁹, Ryosuke Takahashi⁷, Akio Ikeda^7,10, Haruhisa Inoue^1,2,3 (1.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 2.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 3.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Japan, 4.Department of Neurology, National Hospital Organization Utano National Hospital, Japan, 5.Institute of Medical Genetics, Tokyo Women's Medical University, Japan, 6.National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Japan, 7.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 8.Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Japan, 9.Faculty of Medical Sciences, Graduate School of Medicine, Kobe University, Japan, 10.Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Japan)